The importance of FLC testing in MGUS patients

Monoclonal gammopathies of undetermined significance (MGUS) is a widespread phenomenon that increases markedly with age. While MGUS itself requires no medical action, the risk it poses for developing a blood cancer such as MM is 1% per year. Detection and monitoring of MGUS are therefore critical to ensure early discovery of progression to MM. This is important, because the earlier MM is treated, the better the chances of curing the disease. In this webinar, Dr. Gran highlights the key role of FLC testing in the detection and monitoring of MGUS and summarize the results of recent studies.

Charlotte Gran, Karolinska University Hospital

Charlotte Gran, MD, PhD
Department of Clinical Chemistry
Karolinska University Hospital, Sweden​